CLLGSep 14, 2023

Text Classification of Cancer Clinical Trial Eligibility Criteria

arXiv:2309.07812v212 citationsh-index: 3
Originality Incremental advance
AI Analysis

This work addresses the challenge of matching patients to trials for cancer researchers and clinicians, but it is incremental as it focuses on specific criteria rather than a comprehensive solution.

The study tackled the problem of automatically identifying cancer clinical trial eligibility by classifying seven common exclusion criteria from natural language text, achieving the highest average performance using a pre-trained clinical trial BERT model.

Automatic identification of clinical trials for which a patient is eligible is complicated by the fact that trial eligibility is stated in natural language. A potential solution to this problem is to employ text classification methods for common types of eligibility criteria. In this study, we focus on seven common exclusion criteria in cancer trials: prior malignancy, human immunodeficiency virus, hepatitis B, hepatitis C, psychiatric illness, drug/substance abuse, and autoimmune illness. Our dataset consists of 764 phase III cancer trials with these exclusions annotated at the trial level. We experiment with common transformer models as well as a new pre-trained clinical trial BERT model. Our results demonstrate the feasibility of automatically classifying common exclusion criteria. Additionally, we demonstrate the value of a pre-trained language model specifically for clinical trials, which yields the highest average performance across all criteria.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes